AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research
Under the terms of the agreement, AstraZeneca and CSPC agree to discover and develop pre-clinical candidates for multiple targets with the potential to treat diseases across chronic indications, including a pre-clinical small molecule oral therapy for immunological diseases.
AstraZeneca Inks Strategic Collaboration With CSPC | 15/06/2025 | By Darshana | 194
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy